High Content Biology & Cardiac Regeneration: Proliferation and Multi-lineage Differentiation Screens using Cardiac Progenitor Cells
About the Speaker
Lauren Drowley, PhD is an Associate Principal Scientist in the Cardiac Regeneration and Heart Failure disease area at AstraZeneca in Mölndal, Sweden. She received her PhD from University of Pittsburgh focused on stem cell transplantation for myocardial infarct repair and completed a postdoc at AstraZeneca in the UK where she was responsible for developing high content imaging assays with stem/progenitor cell populations for diabetes/obesity indications and examining the role of miRNA in cell differentiation. In her current role as a stem cell specialist, she is involved in characterization of primary adult and iPS-derived stem cell populations, developing and implementing phenotypic proliferation and differentiation assays for cardiac repair, and assessment of potential targets. In addition, she serves as biology lead on several drug projects and manages collaborations with academic partners.
AbstractPhenotypic screens for proliferation and multi-lineage differentiation with relevant human cardiac cell populations has resulted in identification of novel compounds and mechanisms.
Lauren Drowley, PhD is an Associate Principal Scientist in the Cardiac Regeneration and Heart Failure disease area at AstraZeneca in Mölndal, Sweden. She received her PhD from University of Pittsburgh focused on stem cell transplantation for myocardial infarct repair and completed a postdoc at AstraZeneca in the UK where she was responsible for developing high content imaging assays with stem/progenitor cell populations for diabetes/obesity indications and examining the role of miRNA in cell differentiation. In her current role as a stem cell specialist, she is involved in characterization of primary adult and iPS-derived stem cell populations, developing and implementing phenotypic proliferation and differentiation assays for cardiac repair, and assessment of potential targets. In addition, she serves as biology lead on several drug projects and manages collaborations with academic partners.
AbstractPhenotypic screens for proliferation and multi-lineage differentiation with relevant human cardiac cell populations has resulted in identification of novel compounds and mechanisms.
Brought to you by
Interested in seeing more content from SELECTBIO?
Discover all their latest news, webinars, products and more by clicking the link below.
